Background Early detection of maladaptive processes underlying pregnancy-related
pathologies is desirable because it will enable targeted interventions ahead of clinical
manifestations. The quantitative analysis of plasma proteins features prominently among
molecular approaches used to detect deviations from normal pregnancy. However,
derivation of proteomic signatures sufficiently predictive of pregnancy-related outcomes has
been challenging. An important obstacle hindering such efforts were limitations in assay …